| Boyd Miller, MD | |
|
7861 State Road 60, Cedarburg, WI 53012-9305 | |
| (262) 546-1050 | |
| (262) 546-1051 |
| Full Name | Boyd Miller |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 7861 State Road 60, Cedarburg, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548376122 | NPI | - | NPPES |
| 1548376122 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 31069 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Boyd Miller, MD 9000 W Wisconsin Ave, Milwaukee, WI 53226-4874 Ph: (414) 266-7615 | Boyd Miller, MD 7861 State Road 60, Cedarburg, WI 53012-9305 Ph: (262) 546-1050 |
News Archive
Researchers and clinicians from Boston Medical Center (BMC) have been awarded a four year, more than $13 million grant from the National Institutes of Health (NIH) to study neurological and brain abnormalities in former extremely low gestational age newborns.
Lucas McClain started smoking cigarettes in high school but switched to vaping after he heard e-cigarettes were a safer alternative.
The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Later this year, the performance of individual surgeons in the UK will be made publicly available, but the move remains controversial. Researchers in this week's BMJ discuss the issues in relation to cardiothoracic surgery.
Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.
› Verified 6 days ago
Elizabeth Hagen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: N143w6515 Pioneer Rd, Cedarburg, WI 53012 Phone: 262-377-6933 | |
Dr. Matthew Maves, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 | |
Carol J Estill, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 | |
Dr. Lori Ann Albright, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 | |
Elizabeth Ann Doro, MSN, RN, CPNP-AC Pediatrics Medicare: Medicare Enrolled Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 | |
Daniel A Hagerman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: N143w6515 Pioneer Rd, Cedarburg, WI 53012 Phone: 262-377-6399 |